Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC


Scott A. Kirkley, M.D.

Associate Professor of Pathology and Laboratory Medicine
University of Rochester Medical Center

Dr. Kirkley is the Director of the Transfusion Medicine fellowship and the Vice-Chair for Pathology Education overseeing all training programs in the department including the Residency Program, all Fellowship Programs, the Ph.D. program and the Medical Technologist Training Program. He is an Associate Director of the Transfusion Medicine Service and Program Director of the URMC Pathology Residency Training Program. His primary clinical interests include setting up transfusion protocols and helping coordinate laboratory services in support of the organ transplantation programs at Strong Memorial Hospital. He serves on the New York State Council on Human Blood and Transfusion Services. His research efforts include investigating the suppressive effects of allogeneic (homologous) blood transfusion on the immune system. Along with Dr. Neil Blumberg and others, Dr. Kirkley has been comparing the effects of allogeneic, autologous, leukoreduced, and ABO Identical/non-identical blood component transfusions on immune function.

Neil Blumberg, M.D.

Professor of Pathology and Laboratory Medicine
University of Rochester Medical Center

Dr. Blumberg is the Director of Transfusion Medicine/Blood Bank as well as the Director of Clinical Laboratories, Strong Memorial Hospital.  Dr. Blumberg has a long standing interest in training future generations of physician investigators and clinicians in transfusion medicine.  Our fellowship program is new, but many residents from our program have gone on to national leadership positions in transfusion medicine or pathology and laboratory medicine.  Dr. Blumberg’s long term research interests include transfusion immunology, including immunomodulation and clinical outcomes research, platelet biology and transfusion, and the role of the ABO blood group system in bleeding, thrombosis and mortality after ABO non-identical transfusion.  He is the attending physician for the transfusion service one week each month.  Fellows will also have an opportunity, if interested, to participate in research and administrative projects under his mentorship.

Majed A. Refaai, M.D.

Associate Professor of Pathology and Laboratory Medicine
University of Rochester Medical Center

Dr. Refaai is the Director of the thrombosis and hemostasis lab, Associate Director of the Transfusion Medicine/Blood Bank, Associate Director of Apheresis, and Director of the Patient Blood Management Program.   Dr. Refaai received his medical degree from the Aleppo University School of Medicine in Syria. He then joined Massachusetts General hospital/Harvard University in Boston, MA as a research fellow in a special coagulation research lab. Dr. Refaai completed a residency in clinical pathology at the Washington University School of Medicine in St. Louis and held a fellowship in transfusion medicine at the University of Texas Southwestern in Dallas. His research focuses on the in vitro and in vivo effects of ABO antibodies on platelet function and coagulation. He is also involved in clinical trials of emergency reversal of coagulopathy, as well as treatments for deep vein thrombosis and thrombotic thrombocytopenic purpura. Dr. Refaai is board certified in clinical pathology and serves as a reviewer for numerous peer-reviewed journals, including Thrombosis Research, the Journal of Thrombosis and Haemostasis, and the Journal of Clinical Apheresis.      

Jane L. Liesveld, M.D.

Professor of Medicine (Hematology/Oncology); Professor of the JP Wilmot Cancer Institute
University of Rochester Medical Center

Dr. Liesveld is the Medical Director of the Stem Cell Processing Laboratory. She is also a clinical leukemia and stem cell transplantation physician, so she cares for inpatients and outpatients undergoing chemotherapy or stem cell transplantation . Dr. Liesveld completed a residency in Internal Medicine at the University of Rochester/Strong Memorial Hospital, and she also received fellowship training in hematology/oncology at the University of Rochester.  Dr. Liesveld has a long-standing research interest in normal and malignant hematopoiesis as well as in the marrow microenvironment, and her laboratory interests have focused on those areas. As the medical director of the stem cell processing laboratory, Dr. Liesveld serves as liaison between the stem cell processing laboratory and the clinical blood and marrow transplant program. 

Frank Akwaa, M.D.

Assistant Professor, Medicine and Hematology and Oncology
University of Rochester Medical Center

Dr. Akwaa is the Director of Apheresis.  He received his medical degree from the University of Rochester Medical School and completed his Internal medicine residency at Johns Hopkins Bayview Medical Center.  He then completed a hematology/oncology fellowship at the University of Rochester Medical Center.   Dr. Akwaa is board certified in Internal Medicine and Hematology/Oncology.  He has a special interest in benign hematology.

Myra L. Coppage, Ph.D.

Associate Professor of Pathology and Laboratory Medicine
University of Rochester Medical Center

Dr. Coppage is Director of the HLA/Tissue Typing laboratory, which provides state-of-the-art compatibility testing for the solid organ and tissue transplantation services including HLA typing by molecular methods, antibody screening and identification, and crossmatching.  Dr. Coppage's research focuses on B cells and antibodies involved in organ rejection--how they are produced, what effects they have, and what tests can be used to identify them. She is also interested in immune effects of chemotherapeutic agents and immune reconstitution following stem cell transplantation.

Lawrence Fialkow, D.O.

Medical Director, American Red Cross
East Division Blood Services

Dr. Lawrence Fialkow received his medical degree from Des Moines University in Des Moines, Iowa. He underwent post-graduate training in Internal Medicine at Maimonides Medical Center in Brooklyn, New York and the University of Louisville in Louisville, Kentucky. Subsequently, he began post-graduate training in Pathology and Laboratory Medicine at the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania. He completed residency in Anatomical and Clinical Pathology at the University of Rochester Medical Center in Rochester, New York, followed by a fellowship in Transfusion Medicine at Emory University Hospital in Atlanta, Georgia. Dr. Fialkow is board certified in Anatomical Pathology, Clinical Pathology and Transfusion Medicine by the American Board of Pathology.